Kiromic BioPharma Management

Management criteria checks 0/4

Kiromic BioPharma's CEO is Pietro Bersani, appointed in Jan 2022, has a tenure of 1.42 years. total yearly compensation is $697.49K, comprised of 71.2% salary and 28.8% bonuses, including company stock and options. directly owns 2.19% of the company’s shares, worth €60.70K. The average tenure of the management team and the board of directors is 0.9 years and 2.7 years respectively.

Key information

Pietro Bersani

Chief executive officer

US$697.5k

Total compensation

CEO salary percentage71.2%
CEO tenure1.4yrs
CEO ownership2.2%
Management average tenureless than a year
Board average tenure2.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Pietro Bersani's remuneration changed compared to Kiromic BioPharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2023n/an/a

-US$33m

Dec 31 2022US$697kUS$497k

-US$35m

Sep 30 2022n/an/a

-US$39m

Jun 30 2022n/an/a

-US$33m

Mar 31 2022n/an/a

-US$29m

Dec 31 2021US$336kUS$168k

-US$26m

Sep 30 2021n/an/a

-US$19m

Jun 30 2021n/an/a

-US$15m

Mar 31 2021n/an/a

-US$22m

Dec 31 2020US$63kn/a

-US$20m

Compensation vs Market: Pietro's total compensation ($USD697.49K) is above average for companies of similar size in the German market ($USD418.12K).

Compensation vs Earnings: Pietro's compensation has increased whilst the company is unprofitable.


CEO

Pietro Bersani (55 yo)

1.4yrs

Tenure

US$697,486

Compensation

Mr. Pietro Bersani, CPA, J.D., serves as Chief Executive Officer at Kiromic BioPharma, Inc. since May 10, 2022 and serves as Director since January 27, 2022. He serves as Principal Financial Officer at Kir...


Leadership Team

NamePositionTenureCompensationOwnership
Pietro Bersani
CEO, Principal Financial Officer & Director1.4yrsUS$697.49k2.19%
$ 60.7k
Jason Morris
Chief Financial Officerless than a yearno datano data
Leonardo Mirandola
CSO & Interim COOless than a yearno data0.013%
$ 373.5
Scott Dahlbeck
Chief of Staff3.7yrsUS$442.12k0%
$ 0
Timothy Simkiss
Controllerless than a yearno datano data

0.9yrs

Average Tenure

Experienced Management: 5JU0's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Pietro Bersani
CEO, Principal Financial Officer & Director3yrsUS$697.49k2.19%
$ 60.7k
Michael Nagel
Independent Chairperson of the Board2.7yrsUS$214.20k0.64%
$ 17.8k
Ruggero De Maria
Member of Scientific Advisory Boardno datano datano data
Americo Cicchetti
Independent Director3.3yrsUS$187.96k0.64%
$ 17.8k
Amorette Barber
Member of Scientific Advisory Boardno datano datano data
Martin D'Souza
Member of Scientific Advisory Boardno datano datano data
Sandeep Dhanda
Member of Scientific Advisory Boardno datano datano data
Luca Gattinoni
Member of Scientific Advisory Board2.4yrsno datano data
Franco Locatelli
Member of Scientific Advisory Board1.8yrsno datano data

2.7yrs

Average Tenure

56yo

Average Age

Experienced Board: 5JU0's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.